| IIA (n = 58) | EIA (n = 56) | p-value |
---|---|---|---|
Sex | Â | Â | 0.35 |
 Male | 26 (44.8%) | 30 (53.6%) |  |
 Female | 32 (55.2%) | 26 (46.4%) |  |
Age (yrs) | 61 ± 11 | 62 ± 11 | 0.48 |
BMI (kg/m2) | 23.93 ± 3.52 | 22.36 ± 2.87 | 0.01 |
Hb (g/L) | 122.1 ± 23.8 | 117.1 ± 22.7 | 0.26 |
Ab (g/L) | 40.2 ± 4.3 | 38.9 ± 4.8 | 0.12 |
Tumor type | Â | Â | 0.94 |
 Benign | 8 (13.8%) | 10 (17.9%) |  |
 Malignant | 50 (86.2%) | 46 (82.1%) |  |
Tumor site | Â | Â | 0.91 |
 Cecum | 14 (24.1%) | 13 (23.2%) |  |
 Ascending colon | 31 (53.4%) | 32 (57.1%) |  |
 Hepatic flexure | 13 (22.5%) | 11 (19.7%) |  |
Tumor staging | Â | Â | 0.06 |
 I | 17 (34.0%) | 6 (13.0%) |  |
 II | 19 (38.0%) | 24 (52.2%) |  |
 III | 14 (28.0%) | 16 (34.8%) |  |